CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
← catalyst calendarSponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.
Phase
Phase 2
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
46actual
Sites
29
Countries
Australia, France, Germany +4
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-09-20 | actual | When the study began enrolling |
| Primary completion | 2025-01-15 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2022-07-01 | actual | When this record first appeared on the registry |
| Results posted | 2026-03-12 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-04-13 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Sarcoma, Ewing
- Neoplasm Metastasis
Interventions
- Drug: Abemaciclib — also filed as LY2835219
- Drug: Irinotecan
- Drug: Temozolomide
Primary outcomes
what the primary-completion date above is the date OFProgression Free Survival (PFS) Assessed by Blinded Independent Review Committee (BIRC) by Bayesian Analysis
measured From Date of Randomization until Disease Progression or Death Due to Any Cause (Up to 22.36 months)
PFS Assessed by BIRC by Frequentist Analysis
measured From Date of Randomization until Disease Progression or Death Due to Any Cause (Up to 22.36 months)
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2023-08-03 · 3.3 MB · Prot_000.pdf
Statistical Analysis Planposted 2022-06-23 · 661 KB · SAP_001.pdf
Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed